GSK (GSK) Stock: Charts & Financials

GSK plc (GSK)GSKGSK plc

About GSK plc

GSK plc, a global pharmaceutical entity founded in 1715 and headquartered in Brentford, United Kingdom, dedicates its efforts to the research, development, and manufacturing of a wide array of medical solutions. Until May 2022, the company was known as GlaxoSmithKline plc. Its primary objective is to prevent and treat illnesses by producing both vaccines and a comprehensive range of specialty and general medicines for markets across the United Kingdom, the United States, and internationally. The company's operations are organized into two key divisions: Commercial Operations and Total R&D. Its extensive vaccine portfolio includes immunizations against shingles, meningitis, respiratory syncytial virus (RSV), seasonal and pandemic influenza, and polio. Beyond preventative care, GSK provides diverse therapeutic products covering critical areas such as HIV, oncology, respiratory and immunology conditions, and other specialized medical fields. This also encompasses inhaled treatments for chronic respiratory ailments like asthma and chronic obstructive pulmonary disease (COPD), along with antibiotics for various infections. Innovation at GSK is frequently driven by strategic partnerships. Notable collaborations include an agreement with CureVac to advance mRNA-based influenza vaccines, and alliances with Wave Life Sciences and Elsie Biotechnologies focused on developing oligonucleotide platforms. Furthermore, GSK has established two distinct strategic collaborations with Relation to progress therapeutics for fibrotic diseases and osteoarthritis. The company is also engaged in a multi-target strategic alliance aimed at developing pioneering treatments for individuals suffering from Parkinson's disease, and a partnership with Flagship Pioneering to identify novel medicines and vaccines.

London, GL

66,841 employees

www.gsk.com

Healthcare / Drug Manufacturers - General

Sector: Healthcare
Industry: Drug Manufacturers - General
CEO: Luke Victor Miels

View full financials

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Total Current Assets	23.14B	23.14B	30.96B	23.52B	32.29B	33.25B	30.15B	21.27B	23.13B
Cash & Cash Equivalents	4.09B	4.09B	6.00B	4.56B	5.97B	6.77B	7.44B	4.62B	4.27B
Short-Term Investments	1.32M	1.32M	1.74M	12.09M	13.44M	37.63M	35.01M	26.27M	26.75M
Cash & Short-Term Investments	4.09B	4.09B	6.00B	4.57B	5.98B	6.81B	7.48B	4.65B	4.30B
Accounts Receivable	10.64B	10.64B	13.83B	10.42B	15.03B	14.48B	12.51B	7.51B	9.87B
Inventory	8.28B	8.28B	10.73B	7.96B	11.07B	11.43B	10.00B	7.09B	7.91B
Total Assets	81.36B	81.36B	109.58B	82.09B	111.02B	111.50B	101.21B	74.40B	77.63B
Property, Plant & Equipment	13.22B	13.22B	17.50B	13.50B	18.34B	18.66B	16.62B	12.60B	13.01B
Goodwill	9.73B	9.73B	12.70B	9.43B	12.88B	12.67B	11.55B	8.74B	8.93B
Intangible Assets	22.14B	22.14B	31.61B	22.50B	30.52B	28.93B	27.11B	19.41B	20.07B
Long-Term Investments	1.28B	1.28B	1.70B	1.51B	1.96B	1.84B	1.72B	1.52B	1.48B
Total Current Liabilities	28.38B	28.38B	39.09B	28.73B	38.61B	38.34B	34.73B	27.15B	28.70B
Accounts Payable	18.90B	18.90B	24.99B	20.66B	21.07B	27.89B	25.26B	4.33B	19.22B
Short-Term Debt	5.65B	5.65B	8.79B	4.05B	5.17B	3.86B	3.26B	2.73B	3.76B
Total Liabilities	58.72B	58.72B	79.21B	60.57B	82.51B	84.49B	78.45B	58.02B	59.64B
Long-Term Debt	18.38B	18.38B	24.42B	19.76B	26.96B	28.80B	27.47B	17.14B	17.71B
Total Debt	24.03B	24.03B	33.21B	23.80B	32.13B	32.65B	30.73B	21.25B	21.48B
Net Debt (Cash)	19.94B	19.94B	27.21B	19.24B	26.16B	25.88B	23.29B	16.63B	17.21B
Total Shareholders' Equity	23.25B	23.25B	31.12B	22.00B	29.23B	27.83B	23.60B	17.10B	18.73B
Common Stock	1.78B	1.78B	2.35B	1.81B	2.44B	2.54B	2.25B	1.69B	1.80B
Retained Earnings	15.11B	15.11B	20.20B	13.71B	18.13B	16.55B	13.85B	9.75B	10.95B
Current Ratio	0.82	0.82	0.79	0.82	0.84	0.87	0.87	0.78	0.81
Debt to Equity Ratio	1.03	1.03	1.07	1.08	1.10	1.17	1.30	1.24	1.15

Quarterly Report

TTM

Quarter ended Jun 2026

Quarter ended Mar 2026

Quarter ended Dec 2025

Quarter ended Sep 2025

Quarter ended Jun 2025

Quarter ended Mar 2025

Quarter ended Dec 2024

Quarter ended Sep 2024

Total Current Assets

23.14B

30.96B

23.52B

32.29B

33.25B

30.15B

21.27B

23.13B

Cash & Cash Equivalents

4.09B

6.00B

4.56B

5.97B

6.77B

7.44B

4.62B

4.27B

Short-Term Investments

1.32M

1.74M

12.09M

13.44M

37.63M

35.01M

26.27M

26.75M

Cash & Short-Term Investments

4.09B

6.00B

4.57B

5.98B

6.81B

7.48B

4.65B

4.30B

Accounts Receivable

10.64B

13.83B

10.42B

15.03B

14.48B

12.51B

7.51B

9.87B

Inventory

8.28B

10.73B

7.96B

11.07B

11.43B

10.00B

7.09B

7.91B

Total Assets

81.36B

109.58B

82.09B

111.02B

111.50B

101.21B

74.40B

77.63B

Property, Plant & Equipment

13.22B

17.50B

13.50B

18.34B

18.66B

16.62B

12.60B

13.01B

Goodwill

9.73B

12.70B

9.43B

12.88B

12.67B

11.55B

8.74B

8.93B

Intangible Assets

22.14B

31.61B

22.50B

30.52B

28.93B

27.11B

19.41B

20.07B

Long-Term Investments

1.28B

1.70B

1.51B

1.96B

1.84B

1.72B

1.52B

1.48B

Total Current Liabilities

28.38B

39.09B

28.73B

38.61B

38.34B

34.73B

27.15B

28.70B

Accounts Payable

18.90B

24.99B

20.66B

21.07B

27.89B

25.26B

4.33B

19.22B

Short-Term Debt

5.65B

8.79B

4.05B

5.17B

3.86B

3.26B

2.73B

3.76B

Total Liabilities

58.72B

79.21B

60.57B

82.51B

84.49B

78.45B

58.02B

59.64B

Long-Term Debt

18.38B

24.42B

19.76B

26.96B

28.80B

27.47B

17.14B

17.71B

Total Debt

24.03B

33.21B

23.80B

32.13B

32.65B

30.73B

21.25B

21.48B

Net Debt (Cash)

19.94B

27.21B

19.24B

26.16B

25.88B

23.29B

16.63B

17.21B

Total Shareholders' Equity

23.25B

31.12B

22.00B

29.23B

27.83B

23.60B

17.10B

18.73B

Common Stock

1.78B

2.35B

1.81B

2.44B

2.54B

2.25B

1.69B

1.80B

Retained Earnings

15.11B

20.20B

13.71B

18.13B

16.55B

13.85B

9.75B

10.95B

Current Ratio

0.82

0.79

0.82

0.84

0.87

0.78

0.81

Debt to Equity Ratio

1.03

1.07

1.08

1.10

1.17

1.30

1.24

1.15

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Total Current Assets	23.52B	21.27B	30.24B	25.10B	34.23B	37.80B	34.21B	21.56B
Cash & Cash Equivalents	4.56B	4.62B	4.76B	4.50B	7.83B	11.75B	8.26B	4.94B
Short-Term Investments	12.09M	26.27M	3.64B	5.02B	111.81M	145.60M	138.67M	107.01M
Cash & Short-Term Investments	4.57B	4.65B	8.41B	9.52B	7.95B	11.89B	8.40B	5.04B
Accounts Receivable	10.42B	7.51B	12.01B	7.51B	14.72B	13.56B	12.55B	8.05B
Inventory	7.96B	7.09B	8.92B	6.22B	10.60B	11.19B	10.44B	6.98B
Total Assets	82.09B	74.40B	95.70B	72.69B	144.99B	150.14B	139.88B	73.97B
Property, Plant & Equipment	13.50B	12.60B	16.15B	11.63B	19.56B	20.55B	19.86B	14.09B
Goodwill	9.43B	8.74B	11.05B	8.52B	19.34B	19.78B	18.54B	7.37B
Intangible Assets	22.50B	19.41B	23.95B	17.30B	55.13B	55.67B	54.34B	21.91B
Long-Term Investments	1.51B	1.52B	3.47B	-3.16B	5.80B	6.59B	4.22B	1.88B
Total Current Liabilities	28.73B	27.15B	34.17B	27.57B	43.38B	41.34B	42.22B	28.65B
Accounts Payable	20.66B	4.33B	6.03B	4.67B	8.31B	8.13B	7.27B	4.64B
Short-Term Debt	4.05B	2.73B	4.56B	4.57B	6.60B	6.95B	12.14B	7.35B
Total Liabilities	60.57B	58.02B	74.95B	60.49B	105.87B	111.30B	107.66B	69.29B
Long-Term Debt	19.76B	17.14B	22.96B	19.57B	36.22B	42.07B	39.64B	25.77B
Total Debt	23.80B	21.25B	29.22B	25.36B	44.31B	50.68B	53.55B	33.20B
Net Debt (Cash)	19.24B	16.63B	24.46B	20.86B	36.47B	38.94B	45.29B	28.27B
Total Shareholders' Equity	22.00B	17.10B	21.65B	12.81B	27.59B	27.23B	20.02B	4.82B
Common Stock	1.81B	1.69B	2.19B	1.63B	2.47B	2.51B	2.36B	1.71B
Retained Earnings	13.71B	9.75B	11.74B	5.27B	17.95B	16.06B	11.20B	-3.44B
Current Ratio	0.82	0.78	0.88	0.91	0.79	0.91	0.81	0.75
Debt to Equity Ratio	1.08	1.24	1.35	1.98	1.61	1.86	2.67	6.89

Annual Report

12/31/2025

12/31/2024

12/31/2023

12/31/2022

12/31/2021

12/31/2020

12/31/2019

12/31/2018

Total Current Assets

23.52B

21.27B

30.24B

25.10B

34.23B

37.80B

34.21B

21.56B

Cash & Cash Equivalents

4.56B

4.62B

4.76B

4.50B

7.83B

11.75B

8.26B

4.94B

Short-Term Investments

12.09M

26.27M

3.64B

5.02B

111.81M

145.60M

138.67M

107.01M

Cash & Short-Term Investments

4.57B

4.65B

8.41B

9.52B

7.95B

11.89B

8.40B

5.04B

Accounts Receivable

10.42B

7.51B

12.01B

7.51B

14.72B

13.56B

12.55B

8.05B

Inventory

7.96B

7.09B

8.92B

6.22B

10.60B

11.19B

10.44B

6.98B

Total Assets

82.09B

74.40B

95.70B

72.69B

144.99B

150.14B

139.88B

73.97B

Property, Plant & Equipment

13.50B

12.60B

16.15B

11.63B

19.56B

20.55B

19.86B

14.09B

Goodwill

9.43B

8.74B

11.05B

8.52B

19.34B

19.78B

18.54B

7.37B

Intangible Assets

22.50B

19.41B

23.95B

17.30B

55.13B

55.67B

54.34B

21.91B

Long-Term Investments

1.51B

1.52B

3.47B

-3.16B

5.80B

6.59B

4.22B

1.88B

Total Current Liabilities

28.73B

27.15B

34.17B

27.57B

43.38B

41.34B

42.22B

28.65B

Accounts Payable

20.66B

4.33B

6.03B

4.67B

8.31B

8.13B

7.27B

4.64B

Short-Term Debt

4.05B

2.73B

4.56B

4.57B

6.60B

6.95B

12.14B

7.35B

Total Liabilities

60.57B

58.02B

74.95B

60.49B

105.87B

111.30B

107.66B

69.29B

Long-Term Debt

19.76B

17.14B

22.96B

19.57B

36.22B

42.07B

39.64B

25.77B

Total Debt

23.80B

21.25B

29.22B

25.36B

44.31B

50.68B

53.55B

33.20B

Net Debt (Cash)

19.24B

16.63B

24.46B

20.86B

36.47B

38.94B

45.29B

28.27B

Total Shareholders' Equity

22.00B

17.10B

21.65B

12.81B

27.59B

27.23B

20.02B

4.82B

Common Stock

1.81B

1.69B

2.19B

1.63B

2.47B

2.51B

2.36B

1.71B

Retained Earnings

13.71B

9.75B

11.74B

5.27B

17.95B

16.06B

11.20B

-3.44B

Current Ratio

0.82

0.78

0.88

0.91

0.79

0.91

0.81

0.75

Debt to Equity Ratio

1.08

1.24

1.35

1.98

1.61

1.86

2.67

6.89

Balance Sheet

Quarterly Balance Sheet (USD)

Annual Balance Sheet (USD)